Encounter for screening for malignant neoplasm of bladder
- Z12.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM Z12.6 became effective on October 1, 2024.
- This is the American ICD-10-CM version of Z12.6 – other international versions of ICD-10 Z12.6 may differ.
The following code(s) above Z12.6 contain annotation back-references
that may be applicable to Z12.6:
- Z00-Z99 Factors influencing health status and contact with health services
- Z00-Z13 Persons encountering health services for examinations
- Z12 Encounter for screening for malignant neoplasms
Approximate Synonyms
- Screening for cancer of urinary bladder done
- Screening for urinary bladder cancer
Present On Admission
- Z12.6 is considered exempt from POA reporting.
ICD-10-CM Z12.6 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 951 Other factors influencing health status
Convert Z12.6 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to Z12.6:
- Screening (for) Z13.9
- neoplasm (malignant) (of) Z12.9
- bladder Z12.6
- genitourinary organs NECZ12.79
- bladder Z12.6
- neoplasm (malignant) (of) Z12.9